Collaboration key to beating cancer

|6 June 2016| England/South Korea Treating life-threatening diseases such as a cancer will be the target of a pioneering new partnership. Oxford BioMedica and leading South Korean gene and cell therapy...

Important milestone in fight against cancer

Biotechnology company TC BioPharm Ltd (TCB) has announced it has been granted a Clinical Trial Authorisation (CTA) by UK regulators to treat cancer patients with its novel cell therapy – ImmuniCell®. TCB’s l...